The Ohio State University- The James Cancer Hospital and Solove Research Institute

Columbus, Ohio 43210

2 studies enrolling now · 3 studies all time

What they study most

Glioblastoma, Multiple Myeloma (MM), Multiple Myeloma, Newly Diagnosed, Relapsed/Refractory B-cell Malignancies

Studies at this site

• Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma — Recruiting now
• A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies — Recruiting now
• A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1 — Completed